Issue navigation
Volume 189, Issue 3, September 2023
Invited Commentary
Obesity and “functional hypogonadism”—mechanisms and management: commentary on EJE-22-1110 “leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind RCT”
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages R7–R9, https://doi.org/10.1093/ejendo/lvad100
Systematic Review and Meta Analysis
Anorexia nervosa and adrenal hormones: a systematic review and meta-analysis
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages S65–S74, https://doi.org/10.1093/ejendo/lvad123
Original Research
Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 297–308, https://doi.org/10.1093/ejendo/lvad099
A novel approach to hypophysitis: outcomes using non-glucocorticoid immunosuppressive therapy
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 309–317, https://doi.org/10.1093/ejendo/lvad115
High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 318–326, https://doi.org/10.1093/ejendo/lvad113
ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 327–335, https://doi.org/10.1093/ejendo/lvad118
Gender-affirming treatment and mental health diagnoses in Danish transgender persons: a nationwide register-based cohort study
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 336–345, https://doi.org/10.1093/ejendo/lvad119
Bone changes post-sleeve gastrectomy in relation to body mass and hormonal changes
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 346–354, https://doi.org/10.1093/ejendo/lvad121
Early mortality critically impedes improvements in thyroid cancer survival through a half century
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 355–362, https://doi.org/10.1093/ejendo/lvad117
Risk of depression in patients with acromegaly in Korea (2006-2016): a nationwide population-based study
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 363–371, https://doi.org/10.1093/ejendo/lvad120
Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 372–378, https://doi.org/10.1093/ejendo/lvad114
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 379–386, https://doi.org/10.1093/ejendo/lvad124
Identification of a second genetic alteration in patients with SHOX deficiency individuals: a potential explanation for phenotype variability
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 387–395, https://doi.org/10.1093/ejendo/lvad128
Early puberty suppression and gender-affirming hormones do not alter final height in transgender adolescents
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 396–401, https://doi.org/10.1093/ejendo/lvad125
Germline founder variant c.1998delinsTTCT in the RET oncogene: a cohort study in 15 Belgian families
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 402–408, https://doi.org/10.1093/ejendo/lvad126
Identification of myokines susceptible to improve glucose homeostasis after bariatric surgery
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 409–421, https://doi.org/10.1093/ejendo/lvad122
Familial central precocious puberty due to DLK1 deficiency: novel genetic findings and relevance of serum DLK1 levels
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages 422–428, https://doi.org/10.1093/ejendo/lvad129
Brief Report
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis
European Journal of Endocrinology, Volume 189, Issue 3, September 2023, Pages K7–K14, https://doi.org/10.1093/ejendo/lvad127
